Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.39 |
| ▸ | PTGIR | P43119 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27419326 | 0.80 | SLC6A3 (0.55) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11013503 | 0.79 | SLC6A3 (0.77) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14288501 | 0.78 | SLC6A3 (0.57) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7963110 | 0.78 | SLC6A3 (0.57) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11640597 | 0.76 | SLC6A3 (0.55) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7626438 | 0.76 | SLC6A3 (0.50) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11639848 | 0.75 | ALDH1A1 (0.55) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9714837 | 0.74 | SLC6A3 (0.63) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL17429837 | 0.74 | SLC6A3 (0.63) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7959062 | 0.74 | SLC6A3 (0.63) | SLC6A3SLC6A4CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10150736-B2 | Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2018-12-11 | — | — | US | disclosed |
| US-20130273581-A1 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130273581-A1 | HAPTENS AND IMMUNOREACTIVE AGENTS AND USE THEREOF FOR PRODUCING FAMILY ANTIBODIES AND IMMUNOASSAYS FOR QUINOLONES | NQO2, NISCH, VIP | SLC6A3 4327/4885SLC6A4 4274/4885CYP1A2 1400/4885 |
| US-10150736-B2 | Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones | NQO2, NISCH, VIP | SLC6A3 4327/4885SLC6A4 4274/4885CYP1A2 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.